Trading volume in over-the-counter stocks has already surpassed last year’s total in the market that is home to crypto trusts, cannabis sellers and many international stocks
A quirky corner of the U.S. stock market home to cannabis sellers, cryptocurrency trusts and other speculative investments is seeing record levels of activity.
Trading volume in over-the-counter stocks, which aren’t listed on exchanges, has surpassed $548 billion so far this year. That is already more than the total volume for all 2020, according to OTC Markets Group , the company that operates the main marketplace for such securities.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Blockchain Bros and Crypto Socialites Came to PartyPartying with blockchain bros and crypto socialites, by UnhappyFem
Consulte Mais informação »
How to invest wisely in crypto and meme stocks: Two industry pros weigh inMark Hulbert, founder and president of the Hulbert Financial Digest, warns that 'stubborn bullishness' among investors vowing to buy the dip or 'hold on come...
Consulte Mais informação »
Crypto clash? Grayscale’s CEO says SEC’s Gensler ‘shortsighted’ in backing a bitcoin futures ETFFor the next four weeks, we will highlight the most timely news in the crypto and blockchain industry, from developments in digital-asset companies,...
Consulte Mais informação »
Stock futures are flat heading into first full week of trading in OctoberU.S. stock futures were steady in overnight trading on Sunday as investors readied for the first full week of trading in October and the fourth quarter.
Consulte Mais informação »
How to invest wisely in crypto and meme stocks: Two industry pros weigh inMark Hulbert, founder and president of the Hulbert Financial Digest, warns that 'stubborn bullishness' among investors vowing to buy the dip or 'hold on come...
Consulte Mais informação »
Japan stocks set to rise after Merck announces new Covid treatment; China markets closedMerck and Ridgeback Biotherapeutics announced Friday they’ve developed a drug which reduces the risk of hospitalization or death by around 50% in Covid patients.
Consulte Mais informação »